Postoperative adjuvant therapy for resectable rectal cancer Journal Article

  


Author: Minsky, B. D.
Article Title: Postoperative adjuvant therapy for resectable rectal cancer
Abstract: Postoperative combined modality therapy (pelvic radiation plus 5-fluorouracil-based chemotherapy) is the standard adjuvant treatment after surgery for T3 and/or N1-2 rectal cancer. Randomized trials show a significant improvement in local control and survival. Innovative programs using new chemotherapeutic regimens in combination with radiation are in development. Copyright © 2001 by W.B. Saunders Company.
Keywords: cancer survival; cancer surgery; clinical trial; review; fluorouracil; diarrhea; capecitabine; cancer adjuvant therapy; cancer radiotherapy; postoperative care; blood toxicity; irinotecan; folinic acid; operation duration; cancer control; oxaliplatin; rectum cancer; raltitrexed; levamisole; human; 5 ethynyluracil
Journal Title: Seminars in Colon and Rectal Surgery
Volume: 12
Issue: 4
ISSN: 1043-1489
Publisher: Elsevier Inc.  
Date Published: 2001-12-01
Start Page: 194
End Page: 198
Language: English
PROVIDER: scopus
DOI/URL:

http://www.scopus.com/inward/record.url?eid=2-s2.0-0035667372&partnerID=40&md5=01fcc48d0ffa0969a6d0f7310ec2e75c
Notes: Export Date: 21 May 2015 -- Source: Scopus